Enovis Corp Ordinary Shares ENOV 深 沪
等待开盘 10-30 09:30:00 美东时间
31.965
-0.895
-2.72%
华盛通- 最 高33.13
- 今 开32.78
- 成交量 34.18万股
- 最 低 31.93
- 昨 收 32.86
- 总市值 18.26亿
- 52周最高 49.75
- 市盈率 静 --
- 换手率 0.60%
- 52周最低 25.465
- 委 比 -77.08%
- 总股本 5712.31万
- 历史最高 176.11
- 量 比 0.59
- 振 幅 3.65%
- 历史最低 -13.31
- 每 手 1
- 风险率 6.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences
Enovis Corporation will host a third-quarter 2025 earnings conference call on November 6, 2025, at 8:30 a.m. ET and issue an earnings press release earlier that day. The conference call and related materials will be available on the company’s website. Additionally, Enovis’ CEO and CFO will participate in investor conferences on November 9 and November 18, 2025. Investors can access live webcasts and replays on the company’s website. Enovis is an ...
10-24 20:11
Enovix to Release Third Quarter 2025 Financial Results on November 5, 2025
Enovix Corporation, a leader in advanced silicon battery technology, will release its third-quarter financial results on November 5, 2025, followed by a live video call at 2:00 PM PT / 5:00 PM ET to discuss business updates, milestones, and financial results. Investors can register via the provided link and submit questions in advance. Enovix is known for its high-energy-density lithium-ion batteries and operates globally with facilities in India...
10-21 21:07
Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million
Enovis Corporation has sold its Dr. Comfort diabetic shoe business to Promus Equity Partners for up to $60 million. This sale is expected to strengthen Enovis’ core medical technology business, improve profitability, and reduce debt. Promus plans to support Dr. Comfort’s growth and patient care mission. Enovis will discuss the transaction further during its third quarter earnings call on November 6th.
10-08 12:15
Enovix Korea Named 2025 Best Workplace for Job Creation in Korea by Ministry of Employment and Labor
Enovix Korea received the 2025 Best Workplaces of Korea for Job Creation award from the Ministry of Employment and Labor, recognizing its exceptional employee-focused policies, such as profit-sharing, stock purchase plans, transparent communication, and innovative rewards. With only 100 companies honored nationwide, this prestigious award highlights Enovix's commitment to fostering a workplace culture that prioritizes employee engagement, satisfa...
09-12 21:27
Enovix Announces Proposed $300 Million Offering of Convertible Senior Notes Due 2030
Enovix Corporation plans to offer $300 million in convertible senior notes due 2030 in a private placement to qualified institutional buyers under Rule 144A. The notes will accrue interest semiannually and be convertible into cash, shares, or a combination upon certain events. Enovix expects to use proceeds to cover capped call transactions and for general corporate purposes, including potential acquisitions. The company is in preliminary discuss...
09-10 20:07
Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference
Enovis Corporation (NYSE: ENOV) has announced its participation in the Baird 2025 Global Healthcare Conference on September 10, 2025, at 2:35 p.m. ET. A live audio webcast and replay will be available on the Company’s website under the Investors tab. Enovis, an innovation-driven medical technology company, focuses on developing solutions that improve patient outcomes and workflows. Its common stock is listed on the New York Stock Exchange under E...
09-08 20:05
Enovix Announces Completion of Warrant Dividend Program
Enovix Corporation successfully completed its warrant dividend program as all outstanding warrants expired or were exercised by August 29, 2025. Approximately 26.5 million warrants were exercised, generating about $232.1 million in gross proceeds, enhancing the company's capital position to expand its 100% silicon-anode battery technology, accelerate production, and explore acquisitions in the battery sector. The program concluded with no further...
09-05 22:08
Independent Testing Confirms Enovix AI-1™ Battery as Industry’s Highest Energy Density Smartphone Battery
Enovix AI-1TM smartphone battery achieves record-breaking energy density and fast charging, validated by Polaris Battery Labs. Capable of 919 Wh/L and 3C fast charging, Enovix targets the multi-billion-dollar smartphone market with advanced silicon battery technology, positioning itself as a leader in high-performance energy storage solutions.
08-27 12:30
Enovix Appoints Veteran Semiconductor Leader J. Daniel “Dan” McCranie to its Board of Directors
Enovix Corporation appoints J. Daniel "Dan" McCranie to its Board of Directors, expanding the Board to eight members, six of whom are independent. McCranie, with over three decades of experience in public-company governance and leadership in the semiconductor and technology sectors, brings significant expertise to Enovix. His strategic insights will support the company's commercialization and manufacturing expansion. McCranie has held senior role...
08-14 12:52
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
